Design Therapeutics
(NASDAQ:DSGN)
$4.57
0[0.00%]
Last update: 7:40AM Get Real Time Here
Q1 2024 Earnings were released on Wed May 8th, after the market close
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Design Therapeutics Stock (NASDAQ:DSGN), Quotes and News Summary

Design Therapeutics Stock (NASDAQ: DSGN) stock price, news, charts, stock research, profile.

Open$4.630
Close-
Volume / Avg.85.869K / 310.872K
Day Range4.532 - 4.770
52 Wk Range1.940 - 8.470
Market Cap$258.182M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
68
Short Interest
9.4%
Days to Cover7.76

Recent News

Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Avi Kapoor
Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin
Market Sentiment Teeters As US Indices, Including S&P 500, Break Key Supports: Next Levels To Watch
All three leading U.S. stock indices — the S&P 500, Nasdaq 100, and Russell 2000 — have simultaneously breached a crucial technical support level this week.
Piero Cingari
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
0
0
0
0
Nov 23
1
Mar
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.1
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
DSGN
ZURA

FAQ

Q

How do I buy Design Therapeutics (DSGN) stock?

A

You can purchase shares of Design Therapeutics (NASDAQ: DSGN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Design Therapeutics's (DSGN) competitors?

A

Other companies in Design Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Monte Rosa Therapeutics (NASDAQ:GLUE).

Q

What is the target price for Design Therapeutics (DSGN) stock?

A

The latest price target for Design Therapeutics (NASDAQ: DSGN) was reported by Piper Sandler on Tuesday, May 7, 2024. The analyst firm set a price target for 12.00 expecting DSGN to rise to within 12 months (a possible 162.58% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Design Therapeutics (DSGN)?

A

The stock price for Design Therapeutics (NASDAQ: DSGN) is $4.57 last updated Today at May 13, 2024 at 7:40 AM EDT.

Q

Does Design Therapeutics (DSGN) pay a dividend?

A

There are no upcoming dividends for Design Therapeutics.

Q

When is Design Therapeutics (NASDAQ:DSGN) reporting earnings?

A

Design Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.

Q

Is Design Therapeutics (DSGN) going to split?

A

There is no upcoming split for Design Therapeutics.

Q

What sector and industry does Design Therapeutics (DSGN) operate in?

A

Design Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch